Given that patients with active cancer undergo frequent CT scans for diagnosis and monitoring of disease progression, CT is a convenient tool to evaluate body composition and quantify skeletal muscle and adipose tissue and, thus, may aid in the accurate interpretation of SCr or cystatin C‐based eGFR (eGFRCRE and eGFRCYS). This evidence concerns the gene CST3 and cancer.